Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Van de Velde, H.
Right arrow Articles by Van Steirteghem, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van de Velde, H.
Right arrow Articles by Van Steirteghem, A. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 13, 3160-3164, Copyright © 1998 by Oxford University Press

ARTICLES

Effect of timing of oocyte denudation and micro-injection on survival, fertilization and embryo quality after intracytoplasmic sperm injection

H Van de Velde, A De Vos, H Joris, ZP Nagy and AC Van Steirteghem
Centre for Reproductive Medicine, Dutch-speaking Brussels Free University, Belgium.

In human in-vitro fertilization (IVF), the oocytes are surrounded by cumulus and corona cells at the time of insemination so that their maturity cannot easily be evaluated. The best IVF results are obtained if the oocytes are inseminated 2-6 h after retrieval. In the intracytoplasmic sperm injection (ICSI) procedure, the oocytes are denuded by enzymatic and mechanical treatment in order to be able to perform the injection. As a consequence, the nuclear maturity of the oocytes can be evaluated and only those that have extruded the first polar body are injected. However, metaphase-II oocytes that have not yet reached cytoplasmic maturity cannot be recognized. The purpose of this study was to investigate the effect of different timing of cumulus- corona cell removal and injection on the outcome of ICSI. For this we allowed the oocytes to complete in-vitro cytoplasmic maturation in two different culture conditions: (i) surrounded by their cumulus and corona cells or (ii) totally denuded. We performed three different studies on sibling oocytes obtained after a standardized buserelin/human menopausal gonadotrophin (HMG) protocol. We investigated the effect of early (1-2 h after retrieval) and late (5-6 h after retrieval) oocyte denudation and injection on the survival and fertilization of the injected oocytes and on embryo cleavage after fertilization. We found no statistically significant differences between early and late injection, indicating that after a standardized buserelin/HMG protocol the metaphase-II oocytes do not need time for further cytoplasmic maturation. Furthermore, a different timing of cumulus-corona cell removal has no effect on the outcome of ICSI, suggesting that the surrounding cells are not necessary for survival, fertilization and cleavage after ICSI.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
C. Staessen, W. Verpoest, P. Donoso, P. Haentjens, J. Van der Elst, I. Liebaers, and P. Devroey
Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer
Hum. Reprod., December 1, 2008; 23(12): 2818 - 2825.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
A. De Vos, L. Van Landuyt, H. Van Ranst, A. Vandermonde, V. D'Haese, J. Sterckx, P. Haentjens, P. Devroey, and J. Van der Elst
Randomized sibling-oocyte study using recombinant human hyaluronidase versus bovine-derived Sigma hyaluronidase in ICSI patients
Hum. Reprod., August 1, 2008; 23(8): 1815 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
W. Verpoest, M. De Rademaeker, K. Sermon, M. De Rycke, S. Seneca, E. Papanikolaou, C. Spits, L. Van Landuyt, J. Van der Elst, P. Haentjens, et al.
Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis
Hum. Reprod., July 1, 2008; 23(7): 1654 - 1660.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
V. Goossens, M. De Rycke, A. De Vos, C. Staessen, A. Michiels, W. Verpoest, A. Van Steirteghem, C. Bertrand, I. Liebaers, P. Devroey, et al.
Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis
Hum. Reprod., March 1, 2008; 23(3): 481 - 492.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
E.M. Kolibianakis, K. Zikopoulos, W. Verpoest, M. Camus, H. Joris, A.C. Van Steirteghem, and P. Devroey
Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer?
Hum. Reprod., November 1, 2004; 19(11): 2550 - 2554.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P.M. Ciotti, L. Notarangelo, A.M. Morselli-Labate, V. Felletti, E. Porcu, and S. Venturoli
First polar body morphology before ICSI is not related to embryo quality or pregnancy rate
Hum. Reprod., October 1, 2004; 19(10): 2334 - 2339.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
Y. Cohen, M. Malcov, T. Schwartz, N. Mey-Raz, A. Carmon, T. Cohen, J.B. Lessing, A. Amit, and F. Azem
Spindle imaging: a new marker for optimal timing of ICSI?
Hum. Reprod., March 1, 2004; 19(3): 649 - 654.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Jacobs, A. M. Stolwijk, and A. M. M. Wetzels
The effect of insemination/injection time on the results of IVF and ICSI
Hum. Reprod., August 1, 2001; 16(8): 1708 - 1713.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Gianaroli, M. Plachot, R. van Kooij, S. Al-Hasani, K. Dawson, A. DeVos, M.C. Magli, J. Mandelbaum, J. Selva, W. van Inzen, et al.
ESHRE guidelines for good practice in IVF laboratories
Hum. Reprod., October 1, 2000; 15(10): 2241 - 2246.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.